Mary Atwood

1.4k total citations
36 papers, 1.0k citations indexed

About

Mary Atwood is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mary Atwood has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cancer Research, 24 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Mary Atwood's work include Breast Cancer Treatment Studies (25 papers), Global Cancer Incidence and Screening (14 papers) and Breast Lesions and Carcinomas (11 papers). Mary Atwood is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Global Cancer Incidence and Screening (14 papers) and Breast Lesions and Carcinomas (11 papers). Mary Atwood collaborates with scholars based in United States and India. Mary Atwood's co-authors include Henry G. Kaplan, Judith A. Malmgren, J. David Beatty, Xiao Hu, William C. Regli, Wei Sun, Ronald Tickman, Maureen Reiner, Musa Mayer and Jay R. Parikh and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Mary Atwood

36 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Atwood United States 17 482 443 246 187 100 36 1.0k
Rikiya Abe Japan 18 528 1.1× 271 0.6× 244 1.0× 130 0.7× 164 1.6× 122 1.3k
Maria Cuevas Argentina 12 339 0.7× 114 0.3× 57 0.2× 101 0.5× 83 0.8× 20 884
Haocheng Li Canada 18 394 0.8× 357 0.8× 121 0.5× 262 1.4× 31 0.3× 58 1.1k
Hiroyuki Nagata Japan 16 202 0.4× 276 0.6× 37 0.2× 165 0.9× 12 0.1× 73 1.1k
Nisha Sharma United Kingdom 21 394 0.8× 600 1.4× 565 2.3× 196 1.0× 118 1.2× 134 1.4k
Jan Nyman Sweden 33 955 2.0× 425 1.0× 82 0.3× 2.5k 13.5× 87 0.9× 107 4.3k
Timo Lehtonen Finland 20 162 0.3× 163 0.4× 29 0.1× 671 3.6× 5 0.1× 128 1.6k
Luca Nicosia Italy 17 131 0.3× 118 0.3× 106 0.4× 223 1.2× 24 0.2× 82 891
Keisuke Shirai United States 25 903 1.9× 227 0.5× 59 0.2× 466 2.5× 19 0.2× 93 2.0k
Domenico Gattuso Italy 17 268 0.6× 139 0.3× 37 0.2× 94 0.5× 43 0.4× 65 767

Countries citing papers authored by Mary Atwood

Since Specialization
Citations

This map shows the geographic impact of Mary Atwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Atwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Atwood more than expected).

Fields of papers citing papers by Mary Atwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Atwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Atwood. The network helps show where Mary Atwood may publish in the future.

Co-authorship network of co-authors of Mary Atwood

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Atwood. A scholar is included among the top collaborators of Mary Atwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Atwood. Mary Atwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malmgren, Judith A., et al.. (2023). COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019–2021. Breast Cancer Research and Treatment. 202(1). 105–115. 3 indexed citations
2.
Malmgren, Judith A., Mary Atwood, & Henry J. Kaplan. (2023). Abstract P1-05-21: Change in breast cancer detection method, stage at diagnosis and treatment during the COVID-19 Pandemic: 2019-2021. Cancer Research. 83(5_Supplement). P1–5. 1 indexed citations
3.
Kaplan, Henry G., et al.. (2022). Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018. Breast Cancer Research and Treatment. 195(2). 171–180. 4 indexed citations
4.
Kaplan, Henry G., Judith A. Malmgren, & Mary Atwood. (2020). Breast cancer distant recurrence lead time interval by detection method in an institutional cohort. BMC Cancer. 20(1). 1124–1124. 4 indexed citations
5.
Malmgren, Judith A., Marc Hurlbert, Mary Atwood, & Henry G. Kaplan. (2018). Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011. Breast Cancer Research and Treatment. 174(2). 505–514. 17 indexed citations
6.
Malmgren, Judith A., Gregory S. Calip, Shawna M. Pyott, Mary Atwood, & Henry G. Kaplan. (2016). Therapy-related myelodysplastic syndrome following primary breast cancer. Leukemia Research. 47. 178–184. 11 indexed citations
7.
Malmgren, Judith A., Jay R. Parikh, Mary Atwood, & Henry G. Kaplan. (2014). Improved Prognosis of Women Aged 75 and Older with Mammography-detected Breast Cancer. Radiology. 273(3). 686–694. 36 indexed citations
8.
Kaplan, Henry G., Judith A. Malmgren, & Mary Atwood. (2013). Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women. Journal of Geriatric Oncology. 4(2). 148–156. 11 indexed citations
9.
Malmgren, Judith A., Mary Atwood, & Henry G. Kaplan. (2012). Breast Cancer Detection Method Among 20- to 49-Year-Old Patients at a Community Based Cancer Center: 1990-2008. The Breast Journal. 18(3). 257–260. 2 indexed citations
10.
Thorpe, Jason D., et al.. (2011). Irradiation effect after mastectomy on breast cancer recurrence in patients presenting with locally advanced disease. The American Journal of Surgery. 201(5). 605–610. 4 indexed citations
11.
Lowe, Kimberly A., et al.. (2010). Neoadjuvant Chemotherapy of Breast Cancer: Tumor Markers as Predictors of Pathologic Response, Recurrence, and Survival. The Breast Journal. 16(4). no–no. 48 indexed citations
12.
Lowe, Kimberly A., et al.. (2010). Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes. The American Journal of Surgery. 199(5). 625–628. 5 indexed citations
13.
Kaplan, Henry G., Judith A. Malmgren, & Mary Atwood. (2009). T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy. The Breast Journal. 15(5). 454–460. 72 indexed citations
14.
Lowe, Kimberly A., et al.. (2009). Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast. The American Journal of Surgery. 197(5). 643–647. 6 indexed citations
15.
Beatty, J. David, et al.. (2008). Standardized evaluation of regional and institutional breast cancer outcomes. The American Journal of Surgery. 195(5). 636–640. 3 indexed citations
16.
Malmgren, Judith A., Mary Atwood, & Henry G. Kaplan. (2008). Increase in mammography detected breast cancer over time at a community based regional cancer center: a longitudinal cohort study 1990–2005. BMC Cancer. 8(1). 131–131. 18 indexed citations
17.
Tickman, Ronald, et al.. (2006). The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer. Annals of Surgical Oncology. 14(3). 1024–1030. 18 indexed citations
18.
Kaplan, Henry G., Judith A. Malmgren, & Mary Atwood. (2004). Leukemia incidence following primary breast carcinoma treatment. Cancer. 101(7). 1529–1536. 21 indexed citations
19.
Horowitz, Neil S., Matthew A. Powell, Charles W. Drescher, et al.. (2003). Adequate staging for uterine cancer can be performed through Pfannenstiel incisions☆. Gynecologic Oncology. 88(3). 404–410. 7 indexed citations
20.
Horowitz, Neil S., William A. Peters, Michael Smith, et al.. (2002). Adjuvant High Dose Rate Vaginal Brachytherapy as Treatment of Stage I and II Endometrial Carcinoma. Obstetrics and Gynecology. 99(2). 235–240. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rikiya Abe Breakdown of academic impact, for papers by Maria Cuevas Breakdown of academic impact, for papers by Haocheng Li Breakdown of academic impact, for papers by Hiroyuki Nagata Breakdown of academic impact, for papers by Nisha Sharma Breakdown of academic impact, for papers by Jan Nyman Breakdown of academic impact, for papers by Timo Lehtonen Breakdown of academic impact, for papers by Luca Nicosia Breakdown of academic impact, for papers by Keisuke Shirai Breakdown of academic impact, for papers by Domenico Gattuso
Rankless by CCL
2026